Form 4: Sabra Health Care REIT Director Michael J. Foster Reports Stock Sale

Sentiment:

SEC Form 4 Filing


Director Michael J. Foster sold 11,000 shares of Sabra Health Care REIT, Inc. common stock at a price of $18.216 per share on May 20, 2025.

Summary

  • On May 20, 2025, Michael J. Foster, a director of Sabra Health Care REIT, Inc., sold 11,000 shares of common stock.
  • The sale price was $18.216 per share.
  • Following the transaction, Foster directly owns 64,725 shares of common stock.
  • Foster also indirectly owns 42,411.745 shares through a 401(k) plan.
  • The reported holdings include 832 unvested stock units and 52,451 vested but deferred stock units, each representing the right to receive one share of the Issuer's Common Stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting a stock sale by a company director. It doesn't inherently convey positive or negative sentiment, but the market may interpret the sale based on their own analysis.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders of a publicly traded company, like directors or officers, buy or sell the company's securities. These filings provide transparency into the transactions of those with access to non-public information.

Comparison to Industry Standards

  • Comparing this transaction to similar Form 4 filings within the REIT sector could provide context.
  • For example, if executives at Welltower (WELL) or Ventas (VTR) have recently made similar transactions, it could indicate broader trends in executive sentiment within the industry.
  • Analyzing the size of the transaction relative to Foster's total holdings and comparing it to similar insider sales at comparable REITs would be useful.
  • Looking at similar transactions at Omega Healthcare Investors (OHI) or National Health Investors (NHI) would be useful.

Stakeholder Impact

  • Shareholders may react to the news of the director's stock sale, potentially influencing the stock price.
  • The sale could be perceived as a lack of confidence in the company's future prospects, although it could also be for personal financial reasons.

Key Dates

DateDescription
05/20/2025Date of stock sale transaction
05/22/2025Date of signature on the Form 4 filing

Keywords

Sabra Health Care REIT, SBRA, Michael J. Foster, stock sale, director, Form 4, beneficial ownership, securities

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.